|
ZNF238 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.4236999618974E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.03020003428389E-09 |
| Normal-vs-Stage2 |
1.841490E-04 |
| Normal-vs-Stage3 |
2.63580000048336E-08 |
| Normal-vs-Stage4 |
8.426300E-04 |
| Stage1-vs-Stage2 |
5.520400E-01 |
| Stage1-vs-Stage3 |
2.464800E-01 |
| Stage1-vs-Stage4 |
7.426000E-01 |
| Stage2-vs-Stage3 |
2.158000E-01 |
| Stage2-vs-Stage4 |
9.105000E-01 |
| Stage3-vs-Stage4 |
3.541800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.5561999728605E-09 |
| Normal-vs-AfricanAmerican |
4.154300E-02 |
| Normal-vs-Asian |
6.45830000034486E-07 |
| Caucasian-vs-AfricanAmerican |
8.046300E-02 |
| Caucasian-vs-Asian |
8.557400E-01 |
| AfricanAmerican-vs-Asian |
1.110000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.97850000005495E-06 |
| Normal-vs-Female |
2.83820000834822E-09 |
| Male-vs-Female |
5.750000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.76119999695246E-08 |
| Normal-vs-Age(41-60Yrs) |
1.48850000103451E-08 |
| Normal-vs-Age(61-80Yrs) |
1.032720E-04 |
| Normal-vs-Age(81-100Yrs) |
2.756700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.238400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.523000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.674200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.210160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.942400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.478200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.815000E-04 |
| Classical-VS-Follicular |
4.597000E-01 |
| Classical-VS-Other |
8.873000E-01 |
| Classical-VS-Normal |
7.64870000002915E-07 |
| Tall-VS-Follicular |
1.341730E-02 |
| Tall-VS-Other |
9.058100E-02 |
| Tall-VS-Normal |
6.84149958907199E-10 |
| Follicular-VS-Other |
9.155800E-01 |
| Follicular-VS-Normal |
1.43939999996956E-06 |
| Other-VS-Normal |
3.854400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.64720000364704E-08 |
| Normal-vs-N1 |
6.33920000048249E-07 |
| N0-vs-N1 |
3.709800E-01 |
|
|
